Neuroone Medical Technologies Corp
NASDAQ:NMTC
Balance Sheet
Balance Sheet Decomposition
Neuroone Medical Technologies Corp
Current Assets | 5.1m |
Cash & Short-Term Investments | 2.7m |
Receivables | 543.4k |
Other Current Assets | 1.9m |
Non-Current Assets | 729.4k |
PP&E | 645.4k |
Intangibles | 84k |
Current Liabilities | 1.4m |
Accounts Payable | 760k |
Accrued Liabilities | 623.2k |
Non-Current Liabilities | 21k |
Other Non-Current Liabilities | 21k |
Balance Sheet
Neuroone Medical Technologies Corp
Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
0
|
0
|
4
|
7
|
8
|
5
|
|
Cash |
0
|
0
|
4
|
7
|
8
|
5
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
3
|
0
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
1
|
2
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Assets |
0
|
0
|
4
|
7
|
12
|
7
|
|
PP&E Net |
0
|
0
|
0
|
1
|
1
|
1
|
|
PP&E Gross |
0
|
0
|
0
|
1
|
1
|
1
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
0
N/A
|
1
+141%
|
5
+798%
|
8
+67%
|
13
+61%
|
8
-37%
|
|
Liabilities | |||||||
Accounts Payable |
0
|
1
|
1
|
1
|
1
|
1
|
|
Accrued Liabilities |
2
|
1
|
1
|
1
|
1
|
1
|
|
Short-Term Debt |
2
|
0
|
1
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
|
Total Current Liabilities |
4
|
2
|
2
|
1
|
3
|
2
|
|
Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
5
N/A
|
2
-62%
|
3
+52%
|
1
-49%
|
3
+133%
|
2
-43%
|
|
Equity | |||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
10
|
17
|
31
|
41
|
51
|
63
|
|
Additional Paid In Capital |
6
|
16
|
33
|
47
|
60
|
69
|
|
Total Equity |
4
N/A
|
1
+72%
|
2
N/A
|
7
+216%
|
10
+47%
|
6
-35%
|
|
Total Liabilities & Equity |
0
N/A
|
1
+141%
|
5
+798%
|
8
+67%
|
13
+61%
|
8
-37%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
3
|
5
|
7
|
12
|
16
|
24
|